Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination against HIV.

S Norley1, R Kurth

  • 1Paul Ehrlich Institute, Langen, Germany.

Immunobiology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Developing an effective AIDS vaccine remains challenging due to the human immunodeficiency virus (HIV). Research shows progress with animal models, but a practical, large-scale vaccine for public use is still many years away.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.

Cancer gene therapy·2012
Same author

Induction of antibodies binding to the membrane proximal external region of gp36 of HIV-2.

Intervirology·2011
Same author

Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.

Vaccine·2010
Same author

[Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR.

Journal of virological methods·2009
Same journal

WD-3 improves anti-PD-L1 therapy by remodeling the tumor immune microenvironment through gut microbiota.

Immunobiology·2026
Same journal

Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities.

Immunobiology·2026
Same journal

ST2-mediated ERK/JNK/P38/NF-κB signaling: a target of Biminkang mixture in minimal persistent inflammation of allergic rhinitis.

Immunobiology·2026
Same journal

Chronic stress promotes colorectal cancer progression by inducing M2 macrophage polarization and activating the CCL2-CCR2 axis.

Immunobiology·2026
Same journal

Spatial-cellular resolution analysis of ferroptosis-associated immune microenvironment heterogeneity in osteoarthritic cartilage.

Immunobiology·2026
Same journal

Exploring therapeutic targets for neuroinflammation in sepsis-associated encephalopathy: a combined network pharmacology and bioinformatics approach.

Immunobiology·2026
See all related articles

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • The global spread of Acquired Immunodeficiency Syndrome (AIDS) continues despite public health efforts.
  • Developing an effective AIDS vaccine is crucial for epidemiological control but is hindered by the complexity of the human immunodeficiency virus (HIV) and its host interactions.

Purpose of the Study:

  • To identify specific viral proteins and immune responses responsible for protection against HIV infection.
  • To pave the way for the development of large-scale, practical recombinant or synthetic vaccines.

Main Methods:

  • Utilizing the SIVmac animal model system with whole inactivated virus as an immunogen.
  • Evaluating the efficacy of different vaccine approaches in protecting against viral infection.

Related Experiment Videos

Main Results:

  • Successes in the SIVmac model demonstrate that protection against infection is achievable.
  • Whole inactivated virus vaccines show potential but face limitations in efficacy and large-scale production for HIV.

Conclusions:

  • Identifying key viral components and protective immune responses is essential for future vaccine design.
  • Despite promising results in animal models, a proven, practical HIV vaccine is not yet available and will require significant further development.